Abstract
The occurrence and mean content of androgen receptors in the cytosolic fraction of prostatic adenocarcinoma depend on the age of patients, stage of tumor anaplasia, tumor differentiation, type of therapy, and the concentration of androgen receptors.
Similar content being viewed by others
References
L. S. Bassalyk and N. E. Kushlinskii,Vestn. Akad. Med. Nauk SSSR, No. 10, 82–88 (1984).
A. M. Garin,Facts, Achievements, and Failures of Modern Oncology [in Russian], Alma-Ata (1980).
N. E. Kushlinskii, L. S. Bassalyk, and V. G. Degtyar',Med. Radiol., No. 8, 13–15 (1983).
N. E. Kushlinskii, L. S. Bassalyk, B. P. Matveev,et al., Urol. Nefrol., No. 4, 41–46 (1984).
E. B. Marinbakh,Prostatic Cancer [in Russian], Moscow (1980).
B. P. Matveev, V. V. Dvoirin, and E. M. Aksel', in:Diagnostics and Therapy of Oncourological Diseases [in Russian], Moscow (1991), pp. 4–18.
L. S. Bassalyket al. (Eds.),Receptors for Steroid Hormones in Human Tumors [in Russian], Moscow (1987).
G. Chodak,Urology,34, Suppl. 4, 10–12 (1989).
G. Concolino, A. Marocchi, G. Margiotta,et al., Prostate,3, 475–482 (1982).
P. Ekman, M. Snochowsky, A. Zetterberg,et al., Cancer,44, 1173–1181 (1979).
M. Lippman and K. Huff,Ibid.,38, 868–874 (1976).
A. Martelli, M. Soli, E. Bercovich,et al., Urology,16, 245–249 (1980).
B. Mobbs, I. Johnson, G. Connolly, and A. Clark,J. Steroid Biochem.,9, 943–949 (1978).
L. Pertschuk, H. Rosenthal, R. Macchia,et al., Cancer,49, 984–993 (1982).
S. Sidh, J. Young, S. Karmi,et al., Urology,6, 597–603 (1979).
H. De Voogt and P. Dingjan,Urol. Res.,6, 151–158 (1978).
R. Wagner, in:Steroid Receptors, Metabolism and Prostatic Cancer, F. Schroderet al., (Eds.), Amsterdam (1980), pp. 190–198.
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 122, No. 10, pp. 432–436, October, 1996
Rights and permissions
About this article
Cite this article
Kushlinskii, N.E., Gorilovskii, L.M., Ermilova, V.D. et al. Androgen receptors in the cytosolic fraction of malignant prostatic tumors and their clinical significance. Bull Exp Biol Med 122, 1028–1031 (1996). https://doi.org/10.1007/BF02447027
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02447027